Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Transcarent

Explore full profile

New consumer-directed health and care platform for employees of self-insured employers and their families

San Francisco, United StatesFounded 2020Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 500–1k Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Transcarent and the history behind them.

At a glance

Founded
2020
Headquarters
San Francisco, United States
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later13 investors entered at this stage

  • Merck Global Health Innovation Fund
  • Intermountain Healthcare
  • Kleiner Perkins
  • Ally Bridge Group
  • Kinnevik
  • Rush University Medical Center
  • Memorial Hermann Health System
  • Human Capital
  • Threshold Ventures
  • GreatPoint Ventures
  • Leaps by Bayer
  • Geodesic Capital
  • Northwell Health
Employees mapped 836 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States97.1%
🇨🇿 Czech Republic0.9%
🇲🇽 Mexico0.8%
🇷🇸 Serbia0.5%
🇨🇦 Canada0.5%
Top 5 of 6 shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States90%
🇮🇳 India3.9%
🇵🇭 Philippines2.8%
🇨🇦 Canada2.2%
Top 4 markets shown

Patents

Estimated portfolio value
$2M

7 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Transcarent was the backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Transcarent's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Transcarent deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Transcarent's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Transcarent on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Transcarent on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.